WZ-1831

WZ-1831 is a selective inhibitor of the constitutive proteasome β5c subunit (IC50 0.01 μM). WZ-1831 exhibits anticancer activity against multiple myeloma. WZ-1831 synergizes with the β5i-selective inhibitor PKS21265 to induce cytotoxicity. WZ-1831 can be used for research on multiple myeloma.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • CAS. Nr.: 2892822-24-9
  • Formel: C25H29BN4O6
  • Molecular Weight:492.33
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00